Search

everythinglearnresearchcommunity

for

Search:↓

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

Women with PCOS are more likely to have skin problems like excessive hair, acne, and hair loss.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

Women with menstrual dysfunction often have deficiencies in magnesium, iron, and vitamin D.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Finasteride has a higher risk of reproductive side effects than minoxidil.

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.

Finasteride is more harmful to male reproductive health than minoxidil.

Too much prolactin can cause menstrual problems, infertility, and sexual issues in women.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

Adult offspring of sperm donation generally feel positive about their conception and view the donor as their biological father.

Finasteride treats hair loss but may cause low libido, erectile issues, and depression.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.